Recombinant Human Tau441 protein
Be the first to review this product! Submit a review
|
(6 Publications)
Recombinant Human Tau 441 protein is a Human Full Length protein in the 1 to 441 aa range with >90% purity and suitable for western blot and SDS-PAGE. The predicted molecular weight of ab84700 protein is 64 kDa.
- Save time and ensure accurate results - use our recombinant Human Tau-441 (2N4R) protein as a control
- Available in different sizes to fit your experimental needs
View Alternative Names
TAU, MAPT, MSTD, PPND, pTau, DDPAC, MAPTL, MTBT1, MTBT2, Mtapt, Tau-C, FTDP17, RNPTAU, FTDP 17, PHF tau, PHF-tau, 2N3R Tau, 2N4R Tau, AI413597, AW045860, FLJ31424, PPP1R103, MGC134287, MGC138549, MGC156663, TAU_HUMAN, Paired helical filament tau, Paired helical filament-tau, Neurofibrillary tangle protein, Tauopathy and respiratory failure, Microtubule associated protein tau, Microtubule-associated protein tau, Tauopathy and respiratory failure, included, Microtubule associated protein tau isoform 4, Protein phosphatase 1, regulatory subunit 103, G protein beta1/gamma2 subunit interacting factor 1
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human Tau441 protein (AB84700)
SDS-PAGE of ab84700. Approximate MWt 64 kDa (46 kDa by MWt calculation).
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Tau441 is an important component in the assembly and stability of microtubule structures. It associates with other tau isoforms to form a microtubule lattice complex important for neuron polarization and intracellular transport. Tau441 influences cell signaling and synaptic function by regulating microtubule dynamics. It also interacts with motor proteins to facilitate the transport of organelles playing a significant role in maintaining neuron structure and functionality under physiological conditions.
Pathways
Tau441 is involved in the MAP kinase signaling pathway and the regulation of cytoskeleton organization. It interacts with proteins like kinases that phosphorylate tau affecting its microtubule-binding capability highlighting its role in intracellular transport processes. Tau441 modulates the structure and dynamics of microtubules enabling effective transmission of cellular signals and materials throughout the neuron which is vital in maintaining neuronal integrity and function.
Specifications
Form
Liquid
Additional notes
Purity >90% as determined by densitometry.
General info
Function
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
Post-translational modifications
Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1, CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1, MARK2, MARK3 or MARK4), causing detachment from microtubules, and their disassembly (PubMed:23666762, PubMed:7706316). Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tau/MAP's interaction with, respectively, microtubules or plasma membrane components (PubMed:7706316). Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717. Dephosphorylated at several serine and threonine residues by the serine/threonine phosphatase PPP5C.. Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome (By similarity). PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.. O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.. Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle formation in AD.
Subcellular localisation
Cytoskeleton
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2406196 PubMed39297315
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 14:863673 PubMed35645782
2022
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's & dementia : the journal of the Alzheimer's Association 18:2481-2492 PubMed35142027
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Proteins and proteomics 1870:140755 PubMed34999006
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 296:100664 PubMed33865852
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular diagnosis & therapy 22:729-735 PubMed30377977
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com